Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis

por Landau, H, Smith, M, Landry, C, Chou, J F, Devlin, S M, Hassoun, H, Bello, C, Giralt, S, Comenzo, R L
Publicado 2017

P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MYELOMA MAY HAVE A LOWER RISK OF PROGRESSION COMPARED TO WHITE PATIENTS

por Akhlaghi, T., Maclachlan, K., Korde, N., Mailankody, S., Lesokhin, A., Hassoun, H., Lu, S. X., Patel, D., Shah, U., Tan, C., Derkach, A., Lahoud, O., Landau, H. J., Shah, G. L., Scordo, M., Chung, D. J., Giralt, S. A., Usmani, S. Z., Landgren, O., Hultcrantz, M.
Publicado 2022